Date  |
|
| Jan 13, 2020 |
StageZero Life Sciences Retains Fig House Communications to Manage Investor Relations Activities |
| Jan 3, 2020 |
StageZero Life Sciences Announces Conversion of December 2016 Convertible Debentures |
| Dec 9, 2019 |
StageZero Life Sciences Adds BreastSentry and Prostate Health Index to Licensing and Services Agreement with Oncore Pharma |
| Nov 15, 2019 |
StageZero Life Sciences Announces Q3 2019 Progress Update |
| Nov 14, 2019 |
StageZero Life Sciences Expands Telehealth Presence With the Addition of New Partners Including an e-Commerce Platform and Expansion of In-Home Mobile Phlebotomy |
| Nov 13, 2019 |
StageZero Announces 3rd Quarter 2019 Investor Call |
| Nov 6, 2019 |
StageZero Life Sciences Makes ColonSentry(R) Blood Test Available to Consumers Through Online Telehealth Platform |
| Oct 21, 2019 |
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL: Update to Clarify Details Within the Agreement |
| Oct 10, 2019 |
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million |
| Oct 2, 2019 |
StageZero Life Sciences Direct to Consumer Marketing Campaign for Prostate Cancer Awareness Month Attracts Thousands of Responses |